// App-Quantinova.ai

: Pharmacokinetic/Pharmacodynamic Analysis of Amantadine for Levodopa-Induced Dyskinesia: Correlation of Therapeutic Plasma Concentrations from Multiple Species with Humans (S45.006)

Researchers

Presenter

  • Elizabeth Brigham

Principal Investigators

  • Tom Johnston

  • Carl Brown

  • Jonathon Holt

  • Susan Fox

  • Patrick Howson

  • Jonathan Brotchie

  • Jack Nguyen

Medical Centers

  • 4Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson’s Disease, Toronto Western Hospital Toronto ON Canada

  • SickKids Research Institute, Toronto, ON, Canada

  • 2Atuka, Inc. Toronto ON Canada

  • 4Adamas Pharmaceuticals, Inc. Emeryville CA United States

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Amantadine

  • Levodopa

Outcome

  • N/A


Study Design

  • Pharmacokinetics

  • Pharmacodynamics

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A